Literature DB >> 7199335

[Studies on the analysis of propafenone by means of internal analogue standardization (author's transl)].

E Brode, R Sachse, H D Hoffmann.   

Abstract

A high-pressure liquid chromatographic method with internal analogue standardization is described for the determination of 2'-(2-hydroxy-3-propylamino-propoxy)-3-phenylpropiophenone hydrochloride (propafenone, Rytmonorm) in plasma. The requirement of selectivity is met: there is no interference of plasma components and propafenone metabolites found in plasma extracts. When using a 2-ml sample the lower limit of detection is approximately 1 ng/ml, the lower limit of determination about 5 ng/ml. In the concentration range up to 250 ng/ml a mean weighted relative error of about 3% has to be expected.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7199335

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  8 in total

1.  LG 6-101 and LG 6-102, two new propafenone-related antiarrhythmic agents with good oral activity in rats.

Authors:  T C Wascher; P Dittrich; W R Kukovetz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

2.  Tissue distribution of propafenone in the rat after intravenous administration.

Authors:  J Fernández; L Lligoña; A Puigdemont; R Guitart; J L Riu; M Arboix
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Jan-Mar       Impact factor: 2.441

3.  Antiarrhythmic efficacy of propafenone: evaluation of effective plasma levels following single and multiple doses.

Authors:  L Frabetti; B Marchesini; A Capucci; C Cavallini; S Gubelli; E Ambrosioni; B Magnani
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  Beta-blocking and electrophysiological effects of propafenone in volunteers.

Authors:  H Müller-Peltzer; G Greger; G Neugebauer; M Hollmann
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 5.  Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.

Authors:  D W Harron; R N Brogden
Journal:  Drugs       Date:  1987-12       Impact factor: 9.546

Review 6.  Clinical pharmacokinetics of the newer antiarrhythmic agents.

Authors:  A M Gillis; R E Kates
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

7.  Minimal effective concentration values of propafenone and 5-hydroxy-propafenone in acute and chronic therapy.

Authors:  A Capucci; G Boriani; B Marchesini; E Strocchi; L Tomasi; M Balducelli; L Frabetti; E Ambrosioni; B Magnani
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

8.  Severe complications of antianginal drug therapy in a patient identified as a poor metabolizer of metoprolol, propafenone, diltiazem, and sparteine.

Authors:  F Wagner; E Jähnchen; D Trenk; M Eichelbaum; P Harnasch; G Hauf; H Roskamm
Journal:  Klin Wochenschr       Date:  1987-12-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.